Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Radical scavenging of poly(methyl methacrylate) bone cement by rifampin and clinically relevant properties of the rifampin-loaded cement.

Funk GA, Menuey EM, Cole KA, Schuman TP, Kilway KV, McIff TE.

Bone Joint Res. 2019 Mar 2;8(2):81-89. doi: 10.1302/2046-3758.82.BJR-2018-0170.R2. eCollection 2019 Feb.

2.

Endoscopic third ventriculostomy prior to resection of posterior fossa tumors in children.

Frisoli F, Kakareka M, Cole KA, Waanders AJ, Storm PB, Lang SS.

Childs Nerv Syst. 2019 May;35(5):789-794. doi: 10.1007/s00381-019-04125-z. Epub 2019 Mar 20.

PMID:
30895380
3.

Functional Repair Assay for the Diagnosis of Constitutional Mismatch Repair Deficiency From Non-Neoplastic Tissue.

Shuen AY, Lanni S, Panigrahi GB, Edwards M, Yu L, Campbell BB, Mandel A, Zhang C, Zhukova N, Alharbi M, Bernstein M, Bowers DC, Carroll S, Cole KA, Constantini S, Crooks B, Dvir R, Farah R, Hijiya N, George B, Laetsch TW, Larouche V, Lindhorst S, Luiten RC, Magimairajan V, Mason G, Mason W, Mordechai O, Mushtaq N, Nicholas G, Oren M, Palma L, Pedroza LA, Ramdas J, Samuel D, Wolfe Schneider K, Seeley A, Semotiuk K, Shamvil A, Sumerauer D, Toledano H, Tomboc P, Wierman M, Van Damme A, Lee YY, Zapotocky M, Bouffet E, Durno C, Aronson M, Gallinger S, Foulkes WD, Malkin D, Tabori U, Pearson CE.

J Clin Oncol. 2019 Feb 20;37(6):461-470. doi: 10.1200/JCO.18.00474. Epub 2019 Jan 4.

PMID:
30608896
4.

Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib as a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor Models.

Lowery CD, Dowless M, Renschler M, Blosser W, VanWye AB, Stephens JR, Iversen PW, Lin AB, Beckmann RP, Krytska K, Cole KA, Maris JM, Hawkins DS, Rubin BP, Kurmasheva RT, Houghton PJ, Gorlick R, Kolb EA, Kang MH, Reynolds CP, Erickson SW, Teicher BA, Smith MA, Stancato LF.

Clin Cancer Res. 2019 Apr 1;25(7):2278-2289. doi: 10.1158/1078-0432.CCR-18-2728. Epub 2018 Dec 18.

PMID:
30563935
5.

Antibiotic Elution and Mechanical Strength of PMMA Bone Cement Loaded With Borate Bioactive Glass.

Funk GA, Burkes JC, Cole KA, Rahaman MN, McIff TE.

J Bone Jt Infect. 2018 Sep 7;3(4):187-196. doi: 10.7150/jbji.27348. eCollection 2018.

6.

Comprehensive Analysis of Hypermutation in Human Cancer.

Campbell BB, Light N, Fabrizio D, Zatzman M, Fuligni F, de Borja R, Davidson S, Edwards M, Elvin JA, Hodel KP, Zahurancik WJ, Suo Z, Lipman T, Wimmer K, Kratz CP, Bowers DC, Laetsch TW, Dunn GP, Johanns TM, Grimmer MR, Smirnov IV, Larouche V, Samuel D, Bronsema A, Osborn M, Stearns D, Raman P, Cole KA, Storm PB, Yalon M, Opocher E, Mason G, Thomas GA, Sabel M, George B, Ziegler DS, Lindhorst S, Issai VM, Constantini S, Toledano H, Elhasid R, Farah R, Dvir R, Dirks P, Huang A, Galati MA, Chung J, Ramaswamy V, Irwin MS, Aronson M, Durno C, Taylor MD, Rechavi G, Maris JM, Bouffet E, Hawkins C, Costello JF, Meyn MS, Pursell ZF, Malkin D, Tabori U, Shlien A.

Cell. 2017 Nov 16;171(5):1042-1056.e10. doi: 10.1016/j.cell.2017.09.048. Epub 2017 Oct 19.

7.

The functional variant rs34330 of CDKN1B is associated with risk of neuroblastoma.

Capasso M, McDaniel LD, Cimmino F, Cirino A, Formicola D, Russell MR, Raman P, Cole KA, Diskin SJ.

J Cell Mol Med. 2017 Dec;21(12):3224-3230. doi: 10.1111/jcmm.13226. Epub 2017 Jun 30.

8.

Correlation analysis of oral lesion sizes by various standardized criteria.

Flanagan CE, Rhodus NL, Cole KA, Szabo E, Ondrey FG.

Am J Otolaryngol. 2016 Nov - Dec;37(6):502-506. doi: 10.1016/j.amjoto.2016.07.004. Epub 2016 Jul 12.

9.

Preclinical Therapeutic Synergy of MEK1/2 and CDK4/6 Inhibition in Neuroblastoma.

Hart LS, Rader J, Raman P, Batra V, Russell MR, Tsang M, Gagliardi M, Chen L, Martinez D, Li Y, Wood A, Kim S, Parasuraman S, Delach S, Cole KA, Krupa S, Boehm M, Peters M, Caponigro G, Maris JM.

Clin Cancer Res. 2017 Apr 1;23(7):1785-1796. doi: 10.1158/1078-0432.CCR-16-1131. Epub 2016 Oct 11.

10.

Reply to "Urinary Tract Infections: Resistance Is Futile".

Kenney RM, Cole KA, Perri MB, Dumkow LE, Samuel LP, Zervos MJ, Davis SL.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2598. doi: 10.1128/AAC.00011-16. Print 2016 Apr. No abstract available.

11.

Outcomes of Aminopenicillin Therapy for Vancomycin-Resistant Enterococcal Urinary Tract Infections.

Cole KA, Kenney RM, Perri MB, Dumkow LE, Samuel LP, Zervos MJ, Davis SL.

Antimicrob Agents Chemother. 2015 Dec;59(12):7362-6. doi: 10.1128/AAC.01817-15. Epub 2015 Sep 14.

12.

Carboplatin Rechallenge After Hypersensitivity Reactions in Pediatric Patients With Low-Grade Glioma.

Shah AC, Minturn JE, Li Y, Belasco JB, Phillips PC, Kang TI, Cole KA, Waanders AJ, Pollack R, Didomenico C, Wildes C, Fisher MJ.

Pediatr Blood Cancer. 2016 Jan;63(1):21-6. doi: 10.1002/pbc.25697. Epub 2015 Jul 31.

PMID:
26235452
13.

CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus.

Russell MR, Penikis A, Oldridge DA, Alvarez-Dominguez JR, McDaniel L, Diamond M, Padovan O, Raman P, Li Y, Wei JS, Zhang S, Gnanchandran J, Seeger R, Asgharzadeh S, Khan J, Diskin SJ, Maris JM, Cole KA.

Cancer Res. 2015 Aug 1;75(15):3155-66. doi: 10.1158/0008-5472.CAN-14-3613. Epub 2015 Jun 22.

14.

Implementation of an epilepsy self-management protocol.

Cole KA, Gaspar PM.

J Neurosci Nurs. 2015 Feb;47(1):3-9. doi: 10.1097/JNN.0000000000000105.

PMID:
25503542
15.

A 16-year-old boy with a suprasellar mass.

Tamhankar MA, Paessler ME, Kharlip JN, Shekdar KV, Burnham JM, Cole KA.

J Neuroophthalmol. 2014 Sep;34(3):295-300. doi: 10.1097/WNO.0000000000000165. No abstract available.

PMID:
25133884
16.

Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells.

Khanna A, Kauko O, Böckelman C, Laine A, Schreck I, Partanen JI, Szwajda A, Bormann S, Bilgen T, Helenius M, Pokharel YR, Pimanda J, Russel MR, Haglund C, Cole KA, Klefström J, Aittokallio T, Weiss C, Ristimäki A, Visakorpi T, Westermarck J.

Cancer Res. 2013 Nov 15;73(22):6757-69. doi: 10.1158/0008-5472.CAN-13-1002. Epub 2013 Sep 26.

17.

Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma.

Rader J, Russell MR, Hart LS, Nakazawa MS, Belcastro LT, Martinez D, Li Y, Carpenter EL, Attiyeh EF, Diskin SJ, Kim S, Parasuraman S, Caponigro G, Schnepp RW, Wood AC, Pawel B, Cole KA, Maris JM.

Clin Cancer Res. 2013 Nov 15;19(22):6173-82. doi: 10.1158/1078-0432.CCR-13-1675. Epub 2013 Sep 17.

18.

The genetic landscape of high-risk neuroblastoma.

Pugh TJ, Morozova O, Attiyeh EF, Asgharzadeh S, Wei JS, Auclair D, Carter SL, Cibulskis K, Hanna M, Kiezun A, Kim J, Lawrence MS, Lichenstein L, McKenna A, Pedamallu CS, Ramos AH, Shefler E, Sivachenko A, Sougnez C, Stewart C, Ally A, Birol I, Chiu R, Corbett RD, Hirst M, Jackman SD, Kamoh B, Khodabakshi AH, Krzywinski M, Lo A, Moore RA, Mungall KL, Qian J, Tam A, Thiessen N, Zhao Y, Cole KA, Diamond M, Diskin SJ, Mosse YP, Wood AC, Ji L, Sposto R, Badgett T, London WB, Moyer Y, Gastier-Foster JM, Smith MA, Guidry Auvil JM, Gerhard DS, Hogarty MD, Jones SJ, Lander ES, Gabriel SB, Getz G, Seeger RC, Khan J, Marra MA, Meyerson M, Maris JM.

Nat Genet. 2013 Mar;45(3):279-84. doi: 10.1038/ng.2529. Epub 2013 Jan 20.

19.

Combination therapy targeting the Chk1 and Wee1 kinases shows therapeutic efficacy in neuroblastoma.

Russell MR, Levin K, Rader J, Belcastro L, Li Y, Martinez D, Pawel B, Shumway SD, Maris JM, Cole KA.

Cancer Res. 2013 Jan 15;73(2):776-84. doi: 10.1158/0008-5472.CAN-12-2669. Epub 2012 Nov 7.

20.

Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma.

Diskin SJ, Capasso M, Schnepp RW, Cole KA, Attiyeh EF, Hou C, Diamond M, Carpenter EL, Winter C, Lee H, Jagannathan J, Latorre V, Iolascon A, Hakonarson H, Devoto M, Maris JM.

Nat Genet. 2012 Oct;44(10):1126-30. doi: 10.1038/ng.2387. Epub 2012 Sep 2.

21.

A comparison of screening methods in two early phase oral leukoplakia clinical trials.

Rosas RR, Cole KA, Darrah L, Rohrer MD, Rhodus NL, Ondrey FG.

Oral Dis. 2012 Oct;18(7):720-3. doi: 10.1111/j.1601-0825.2012.01934.x. Epub 2012 Apr 24.

22.

New strategies in refractory and recurrent neuroblastoma: translational opportunities to impact patient outcome.

Cole KA, Maris JM.

Clin Cancer Res. 2012 May 1;18(9):2423-8. doi: 10.1158/1078-0432.CCR-11-1409. Epub 2012 Mar 16.

23.

Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity.

Bosse KR, Diskin SJ, Cole KA, Wood AC, Schnepp RW, Norris G, Nguyen le B, Jagannathan J, Laquaglia M, Winter C, Diamond M, Hou C, Attiyeh EF, Mosse YP, Pineros V, Dizin E, Zhang Y, Asgharzadeh S, Seeger RC, Capasso M, Pawel BR, Devoto M, Hakonarson H, Rappaport EF, Irminger-Finger I, Maris JM.

Cancer Res. 2012 Apr 15;72(8):2068-78. doi: 10.1158/0008-5472.CAN-11-3703. Epub 2012 Feb 20.

24.

RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma.

Cole KA, Huggins J, Laquaglia M, Hulderman CE, Russell MR, Bosse K, Diskin SJ, Attiyeh EF, Sennett R, Norris G, Laudenslager M, Wood AC, Mayes PA, Jagannathan J, Winter C, Mosse YP, Maris JM.

Proc Natl Acad Sci U S A. 2011 Feb 22;108(8):3336-41. doi: 10.1073/pnas.1012351108. Epub 2011 Feb 2.

25.

Integrative genomics identifies LMO1 as a neuroblastoma oncogene.

Wang K, Diskin SJ, Zhang H, Attiyeh EF, Winter C, Hou C, Schnepp RW, Diamond M, Bosse K, Mayes PA, Glessner J, Kim C, Frackelton E, Garris M, Wang Q, Glaberson W, Chiavacci R, Nguyen L, Jagannathan J, Saeki N, Sasaki H, Grant SF, Iolascon A, Mosse YP, Cole KA, Li H, Devoto M, McGrady PW, London WB, Capasso M, Rahman N, Hakonarson H, Maris JM.

Nature. 2011 Jan 13;469(7329):216-20. doi: 10.1038/nature09609. Epub 2010 Dec 1.

26.

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma.

Capasso M, Devoto M, Hou C, Asgharzadeh S, Glessner JT, Attiyeh EF, Mosse YP, Kim C, Diskin SJ, Cole KA, Bosse K, Diamond M, Laudenslager M, Winter C, Bradfield JP, Scott RH, Jagannathan J, Garris M, McConville C, London WB, Seeger RC, Grant SF, Li H, Rahman N, Rappaport E, Hakonarson H, Maris JM.

Nat Genet. 2009 Jun;41(6):718-23. doi: 10.1038/ng.374. Epub 2009 May 3.

27.

Identification of ALK as a major familial neuroblastoma predisposition gene.

Mossé YP, Laudenslager M, Longo L, Cole KA, Wood A, Attiyeh EF, Laquaglia MJ, Sennett R, Lynch JE, Perri P, Laureys G, Speleman F, Kim C, Hou C, Hakonarson H, Torkamani A, Schork NJ, Brodeur GM, Tonini GP, Rappaport E, Devoto M, Maris JM.

Nature. 2008 Oct 16;455(7215):930-5. doi: 10.1038/nature07261. Epub 2008 Aug 24.

28.

A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene.

Cole KA, Attiyeh EF, Mosse YP, Laquaglia MJ, Diskin SJ, Brodeur GM, Maris JM.

Mol Cancer Res. 2008 May;6(5):735-42. doi: 10.1158/1541-7786.MCR-07-2102.

29.

Chromosome 6p22 locus associated with clinically aggressive neuroblastoma.

Maris JM, Mosse YP, Bradfield JP, Hou C, Monni S, Scott RH, Asgharzadeh S, Attiyeh EF, Diskin SJ, Laudenslager M, Winter C, Cole KA, Glessner JT, Kim C, Frackelton EC, Casalunovo T, Eckert AW, Capasso M, Rappaport EF, McConville C, London WB, Seeger RC, Rahman N, Devoto M, Grant SF, Li H, Hakonarson H.

N Engl J Med. 2008 Jun 12;358(24):2585-93. doi: 10.1056/NEJMoa0708698. Epub 2008 May 7.

30.

Anaerobic nitrate-dependent iron(II) bio-oxidation by a novel lithoautotrophic betaproteobacterium, strain 2002.

Weber KA, Pollock J, Cole KA, O'Connor SM, Achenbach LA, Coates JD.

Appl Environ Microbiol. 2006 Jan;72(1):686-94.

31.

Biological control of hog waste odor through stimulated microbial Fe(III) reduction.

Coates JD, Cole KA, Michaelidou U, Patrick J, McInerney MJ, Achenbach LA.

Appl Environ Microbiol. 2005 Aug;71(8):4728-35.

32.

Long-term follow-up of a longitudinal faculty development program in teaching skills.

Knight AM, Cole KA, Kern DE, Barker LR, Kolodner K, Wright SM.

J Gen Intern Med. 2005 Aug;20(8):721-5.

33.

More than doctors' communication skills.

Kern DE, Cole KA.

Med Educ. 2005 May;39(5):445-7. No abstract available.

PMID:
15842677
34.

Pesticide residues in water, sediment, and fish at the SpartaI, IL, USA, National Guard Armory.

Ownby DR, Trimble TA, Cole KA, Lydy MJ.

Bull Environ Contam Toxicol. 2004 Nov;73(5):802-9. No abstract available.

PMID:
15669722
35.

Faculty development in teaching skills: an intensive longitudinal model.

Cole KA, Barker LR, Kolodner K, Williamson P, Wright SM, Kern DE.

Acad Med. 2004 May;79(5):469-80.

PMID:
15107288
36.

Rb regulates C/EBPbeta-DNA-binding activity during 3T3-L1 adipogenesis.

Cole KA, Harmon AW, Harp JB, Patel YM.

Am J Physiol Cell Physiol. 2004 Feb;286(2):C349-54. Epub 2003 Oct 22.

37.

Metalloporphyrin probes for antimalarial drug action.

Ziegler J, Pasierb L, Cole KA, Wright DW.

J Inorg Biochem. 2003 Sep 1;96(4):478-86.

PMID:
13678814
38.

Diversity and ubiquity of bacteria capable of utilizing humic substances as electron donors for anaerobic respiration.

Coates JD, Cole KA, Chakraborty R, O'Connor SM, Achenbach LA.

Appl Environ Microbiol. 2002 May;68(5):2445-52.

39.

Evaluation of non-formalin tissue fixation for molecular profiling studies.

Gillespie JW, Best CJ, Bichsel VE, Cole KA, Greenhut SF, Hewitt SM, Ahram M, Gathright YB, Merino MJ, Strausberg RL, Epstein JI, Hamilton SR, Gannot G, Baibakova GV, Calvert VS, Flaig MJ, Chuaqui RF, Herring JC, Pfeifer J, Petricoin EF, Linehan WM, Duray PH, Bova GS, Emmert-Buck MR.

Am J Pathol. 2002 Feb;160(2):449-57.

40.
41.

Anaerobic benzene oxidation coupled to nitrate reduction in pure culture by two strains of Dechloromonas.

Coates JD, Chakraborty R, Lack JG, O'Connor SM, Cole KA, Bender KS, Achenbach LA.

Nature. 2001 Jun 28;411(6841):1039-43.

PMID:
11429602
42.

Molecular profiling of clinical tissues specimens: feasibility and applications.

Emmert-Buck MR, Strausberg RL, Krizman DB, Bonaldo MF, Bonner RF, Bostwick DG, Brown MR, Buetow KH, Chuaqui RF, Cole KA, Duray PH, Englert CR, Gillespie JW, Greenhut S, Grouse L, Hillier LW, Katz KS, Klausner RD, Kuznetzov V, Lash AE, Lennon G, Linehan WM, Liotta LA, Marra MA, Munson PJ, Ornstein DK, Prabhu VV, Prang C, Schuler GD, Soares MB, Tolstoshev CM, Vocke CD, Waterston RH.

J Mol Diagn. 2000 May;2(2):60-6. Review. No abstract available.

43.

The propionate of heme binds N4O2 Schiff base antimalarial drug complexes.

Ziegler J, Schuerle T, Pasierb L, Kelly C, Elamin A, Cole KA, Wright DW.

Inorg Chem. 2000 Aug, 7;39(16):3731-3. No abstract available.

PMID:
11196844
44.
45.

Capillary electrophoretic determination of carboxyhemoglobin concentrations in postmortem blood samples.

Durkin DP, Cole KA, Copper CL.

J Capillary Electrophor. 1998 May-Aug;5(3-4):129-32.

PMID:
10797877
46.

Metalloporphyrins inhibit beta-hematin (hemozoin) formation.

Cole KA, Ziegler J, Evans CA, Wright DW.

J Inorg Biochem. 2000 Jan 30;78(2):109-15.

PMID:
10766333
47.

Molecular profiling of clinical tissue specimens: feasibility and applications.

Emmert-Buck MR, Strausberg RL, Krizman DB, Bonaldo MF, Bonner RF, Bostwick DG, Brown MR, Buetow KH, Chuaqui RF, Cole KA, Duray PH, Englert CR, Gillespie JW, Greenhut S, Grouse L, Hillier LW, Katz KS, Klausner RD, Kuznetzov V, Lash AE, Lennon G, Linehan WM, Liotta LA, Marra MA, Munson PJ, Ornstein DK, Prabhu VV, Prange C, Schuler GD, Soares MB, Tolstoshev CM, Vocke CD, Waterston RH.

Am J Pathol. 2000 Apr;156(4):1109-15. Review. No abstract available.

48.

The genetics of cancer--a 3D model.

Cole KA, Krizman DB, Emmert-Buck MR.

Nat Genet. 1999 Jan;21(1 Suppl):38-41. Review.

PMID:
9915499
49.

Histopathology and molecular biology of ovarian epithelial tumors.

Chuaqui RF, Cole KA, Emmert-Buck MR, Merino MJ.

Ann Diagn Pathol. 1998 Jun;2(3):195-207. Review.

PMID:
9845739
50.

cDNA sequencing and analysis of POV1 (PB39): a novel gene up-regulated in prostate cancer.

Cole KA, Chuaqui RF, Katz K, Pack S, Zhuang Z, Cole CE, Lyne JC, Linehan WM, Liotta LA, Emmert-Buck MR.

Genomics. 1998 Jul 15;51(2):282-7.

PMID:
9722952

Supplemental Content

Support Center